University at Buffalo - The State University of New York
Skip to Content
Drucy                          Borowitz

Drucy S. Borowitz MD

Department of Pediatrics

Clinical Professor

Specialty/Research Focus

Pediatric Pulmonology; Pediatrics

 

Education and Training:
  • Fellowship, Clinical Nutrition/Gastroenterology, University of California, San Francisco School of Medicine (1983)
  • Residency, Pediatrics, University of California, San Francisco School of Medicine (1982)
  • Internship, Pediatrics, University of Pennsylvania School of Medicine (1980)
  • MD, Medicine, Cornell University Weill Medical College (1979)
  • BA, Psychology, Brandeis University, cum laude (1975)
Employment:
  • Vice President for Community Partnerships, Cystic Fibrosis Foundation (2016-present)
  • Clinical Professor, Pediatrics, University at Buffalo (2004-present)
  • Associate Attending Physician, Division of Gastroenterology, UBMD Pediatrics, Women and Children‘s Hospital of Buffalo (1988-present)
  • Associate Director, Cystic Fibrosis Center, Women and Children‘s Hospital of Buffalo (2014–2015)
  • Director, Cystic Fibrosis Center, Women and Children‘s Hospital of Buffalo (1989–2014)
  • Chief, Division of Pulmonology, UBMD Pediatrics, Women and Children‘s Hospital of Buffalo (1997–2010)
  • Clinical Associate Professor, Pediatrics, University at Buffalo (1996–2004)
  • Vice Chair of Specialist Practice, Pediatrics, University at Buffalo (1997–1998)
  • Acting Chief, Division of Pulmonology, UBMD Pediatrics, Women and Children‘s Hospital of Buffalo (1992–1997)
  • Clinical Assistant Professor, Social and Preventive Medicine, Social and Preventive Medicine, University at Buffalo (1990–1996)
  • Clinical Assistant Professor, Pediatrics, University at Buffalo (1988–1996)
  • Director, Shapedown Program, Women and Children‘s Hospital of Buffalo (1990–1992)
  • Acting Instructor, Pediatrics, Children‘s Hospital Medical Center, University of Washington (1986–1988)
  • Associate, Pediatrics, Gershman, Sollod and Verhoogen (1983–1986)
See all (4 more)
Awards and Honors:
  • Cystic Fibrosis Foundation: CFsational Women of WNY Award (2015)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Stockton Kimball Award (2015)
  • University at Buffalo: Exceptional Scholar - Sustained Achievement Award (2014)
  • Buffalo Spree: Best Doctors in Western New York - Featured Article (2014)
  • Cystic Fibrosis Foundation: Richard C. Talamo Distinguished Clinical Achievement Award (2013)
  • Women and Children‘s Hospital of Buffalo: Children‘s Champion (2013)
  • Buffalo Spree Magazine: Best Doctors in Western New York (2012)
  • Buffalo Spree Magazine: Best Doctors in Western New York (2011)
  • Cornell Club of Greater Buffalo: Distinguished Alumna Award (2011)
  • Business First: Healthcare 50 for 2010 (2010)
  • Buffalo Spree Magazine: Best Doctors in Western New York (2009)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Siegel Awards Program Excellence in Teaching Commendation (2008)
  • Buffalo Spree Magazine: Best Doctors in Western New York (2005)
  • Cited - Guide to America‘s Top Pediatricians (2004)
  • Best Doctors in America (2003)
  • Kaleida Health: Distinguished Doctor Nominee (2002)
  • Women and Children‘s Hospital of Buffalo: Burt P. Flickinger, Jr. Physician Award (2002)
  • Cystic Fibrosis Foundation: Parade of Stars Awardee (2001)
  • North American Cystic Fibrosis Conference: Co-Chair (1996)
  • Women and Children‘s Hospital of Buffalo: Employee of Excellence Award (1991)
  • Children‘s Hospital Medical Center: Pediatric Teaching Award (1988)
  • Best Doctors in America: Northeast Region (1996-present)
  • Castle Connolly Medical Ltd: America‘s Top Doctors (2014-2016)

Research Expertise:
  • Cystic fibrosis
Grants and Sponsored Research:
  • July 2014–June 2018
    PROSPECT GI pH Sub-Study and GIFT Breath Testing Sub-Study
    Cystic Fibrosis Foundation Therapeutics
    Role: Principal Investigator
    $116,524
  • January 2015–December 2016
    Additional Research Coordinator (ARC) Award
    Cystic Fibrosis Foundation Therapeutics
    Role: Principal Investigator
    $96,957
  • December 2011–April 2016
    BONUS study - Site costs
    Seattle Children‘s Hospital
    Role: Principal Investigator
    $14,607
  • January 2015–December 2015
    Therapeutics Developmental Center (TDC)
    Cystic Fibrosis Foundation Therapeutics
    Role: Principal Investigator
    $90,342
  • January 2015–December 2015
    A Phase 3, Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Lumacaftor in Combination with Ivacaftor in Subjects 6 through 11 Years of Age with Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation
    Vertex Pharmaceuticals
    Role: Co-Investigator
  • February 2015–July 2015
    TDN Spring Meeting Supplement
    Cystic Fibrosis Foundation Therapeutics
    Role: Principal Investigator
    $3,645
  • July 2014–June 2015
    Expression-Based Biomarkers in Cystic Fibrosis
    University at Buffalo Clinical and Translational Research Fund
    Role: Co-Investigator
    $34,190
  • July 2014–June 2015
    PROSPECT GI pH Sub-Study and GIFT Breath Testing Sub-Study Addendum
    Cystic Fibrosis Foundation Therapeutics
    Role: Principal Investigator
    $12,636
  • December 2010–December 2014
    A Phase 2, Multicenter, Double-Blinded, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of VX-809 Alone in Combination with VX-770 in Subjects with Cystic Fibrosis
    Vertex Pharmaceuticals
    Role: Principal Investigator
    $101,271
  • January 2013–January 2014
    A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Efficacy and Safety of Lumacaftor in Combination with Ivacaftor in Subjects Aged 12 Years and Older with Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
    Vertex Pharmaceuticals
    Role: Co-Investigator
  • January 2012–January 2013
    G551D Observational Study (GOAL) Gastrointestinal pH sub-study
    Cystic Fibrosis Foundation
    Role: Co-Principal Investigator
  • January 2011–January 2013
    Longitudinal Cohort Study to Collect Biospecimens from Healthy Infants in the First Year of Life
    Cystic Fibrosis Foundation Therapeutics
    Role: Co-Principal Investigator
  • January 2010–January 2013
    iCARE: I Change Expectations and Raise Adherence
    Cystic Fibrosis Foundation/Genentech, Inc./Novartis Pharmaceuticals Corporation
    Role: Co-Investigator
  • January 2015
    A Two-Part Prospective, Longitudinal Study of CFTR-Dependent Disease Profiling in Cystic Fibrosis (PROSPECT)
    Cystic Fibrosis Foundation Therapeutics
    Role: Co-Investigator
  • January 2014
    Coordinating Center for pH Pill and Breath Testing Substudies of a Two-Part Prospective Longitudinal Study of CFTR-Dependent Disease Profiling in Cystic Fibrosis (PROSPECT)
    Cystic Fibrosis Foundation Therapeutics
    Role: Co-Investigator
  • January 2014
    A Point Prevalence Study to Evaluate the Prevalence of Antibodies to Selected Porcine Viruses in Patients with Cystic Fibrosis who are Receiving Porcine-Derived Pancreatic Enzyme Replacement Therapy: A Harmonized Protocol Across Sponsors
    AbbVie, Inc./Aptalis Pharma US, Inc./Janssen Research and Development, LLC
    Role: Principal Investigator
    $25,295
  • January 2014
    A Phase 3, Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lumacaftor in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation
    Vertex Pharmaceuticals
    Role: Co-Investigator
  • January 2012
    A Multi-Center, Randomized, Controlled, Double-Blind Study of the Effects of an Antioxidant-Enriched Multivitamin Supplement on Inflammation and Oxidative Stress in Cystic Fibrosis Patients
    Cystic Fibrosis Foundation Therapeutics
    Role: Principal Investigator
    $25,751
  • January 2012
    A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multicenter Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy (CAT) Regimen of Inhaled Antibiotics for the Treatment of Chronic Pulmonary Pseudomonas aeruginosa
    Gilead Pharmaceuticals
    Role: Co-Investigator
  • January 2012
    G551D Observational Study (GOAL)
    Cystic Fibrosis Foundation
    Role: Co-Investigator
  • January 2011
    A Long-Term Prospective Observational Study of the Incidence of and Risk Factors for Fibrosing Colonopathy in US Patients with Cystic Fibrosis Treated with Pancreatic Enzyme Replacement Therapy: A Harmonized Protocol Across Sponsors
    Cystic Fibrosis Foundation Therapeutics
    Role: Contributor
  • January 2011
    Baby Observational and Nutritional Study of Cystic Fibrosis
    Cystic Fibrosis Foundation Therapeutics
    Role: Principal Investigator
    $221,621
  • January 2011
    A Randomized Cross-Over Study of Two Different Doses of Porcine Pancreatic Enzyme Replacement Therapy in Young Infants with Cystic Fibrosis
    Cystic Fibrosis Foundation Therapeutics
    Role: Consultant
  • January 2008
    Longitudinal Study of Patients with Cystic Fibrosis and Established Cirrhosis (LOCi)
    National Institute of Diabetes and Digestive and Kidney Diseases/Cystic Fibrosis Foundation
    Role: Consultant
  • January 2008
    Prediction by Ultrasound of the Risk of Heptic Cirrhosis in Cystic Fibrosis (PUSH)
    National Institute of Diabetes and Digestive and Kidney Diseases/Cystic Fibrosis Foundation
    Role: Consultant
  • January 2004
    Early Pseudomonas Infection Control (EPIC) Observational Study
    Cystic Fibrosis Foundation Therapeutic Development Network
    Role: Co-Investigator
  • January 2003
    Nutritional and Gastrointestinal Issues in CF
    Cystic Fibrosis Foundation Therapeutics, Inc.
    Role: Consultant
See all (17 more)

Journal Articles:
See all (55 more)
Abstracts:
  • Sagel SD, Baines A, Abdulhamid I, Borowitz DS. Effects of an Antioxidant-Enriched Multivitamin Supplement on Inflammation and Oxidative Stress in CF. Pediatr Pulmonol. 2016; 51(S45).
  • Goetz DM, Ma C, Westley M, Howard B, Borowitz DS. Lung Clearance Index Testing and Satisfaction Compared to Spirometry and Plethysmography. Pediatr Pulmonol. 2016; 51(S45).
  • Grimely ME, Saunders J, Walter M, Roach C, Borowitz DS, Dellon EP. Communication About Prognosis in Cystic Fibrosis. Pediatr Pulmonol. 2015; 50(S41).
  • Fries L, Savant AP, Berger A, Nufer J, Roach CM, Smith BA, Cogswell A, Borowitz DS. Routine Depression Screening: Dissemination of a Standardized Depression Screening and Intervention Process. Pediatr Pulmonol. 2015; 50(S41).
  • Roach CM, Smith BA, Cogswell A, Borowitz DS. Routine Depression Screening: Patient Perceptions and Satisfaction. Pediatr Pulmonol. 2015; 50(S41).
  • Leung DH, Borowitz DS, Heltshe SL, Kloster M, Gelfond D, Heubi J, Hocevar-Trnka J, Ramsey B. CF Infant Growth and Pulmonary Status in the First Year of Life. Pediatr Pulmonol. 2015; 50(S41).
  • Heltshe SL, Leung DH, Kloster M, Gelfond D, Heubi JR, Borowitz DS, Ramsey B. Clinical Blood Hematology and Chemistry in CF Infants. Pediatr Pulmonol. 2015; 50(S41).
  • Gelfond D, Heubi JE, Kloster M, Heltshe SL, Borowitz DS, Leung DH, Ramsey B. Pancreatic Enzyme Use in Infants with CF in the First Year of Life. Pediatr Pulmonol. 2015; 50(S41).
  • Singh S, Frederick CA, Borowitz DS. Using Video Conferencing for Parent and Patient Advisory Group in Era of Infection Control. Pediatr Pulmonol. 2015; 50(S41).
  • McColley SA, Danders D, Michelson P, Petren K, Marshall BC, Farrell PM, Borowitz DS. A State Level Registry for Assessment of Cystic Fibrosis Newborn Screening Programs. Pediatr Pulmonol. 2014; 49(S38).
  • Frederick CA, Goetz DM, Borowitz DS, Surace B. Patient and Family Perceptions of the New Infection Prevention and Control Guidelines. Pediatr Pulmonol. 2014; 49(S38).
  • Rowe SM, Heltshe SL, Gonska T, Donaldson S, Borowitz DS, Gelfond D, Sagel SD, Khan U, Hamblett NM, VanDalfsen J, Joseloff E, Ramsey B. Results of the G551D Observational Study: the Effect of Ivacaftor on G551D Patients Following FDA Approval. Pediatr Pulmonol. 2013; 48(S36).
  • Borowitz DS. Long-Term Safety and Efficacy of Ivacaftor in Patients with Cystic Fibrosis who have the G551D-CFTR Mutation: Response through 144 Weeks of Treatment (96 Weeks of PERSIST). Pediatr Pulmonol. 2013; 48(S36).
  • Gelfond D, Borowitz DS, Frederick CA, Uluer A, Sicilian L, Konstan MW, Rowe SM. Impact of Ivacaftor Therapy on the Intestinal pH Profile in CF Subjects with the G551D Mutation. Pediatr Pulmonol. 2013; 48(S36).
  • Baier R, Meyer AE, Aronica MJ, Merrick JM, Borowitz DS, Murphy TM. Induced Biofilm-Matrix Collapse Fluidizes Cystic Fibrosis Sputum. University at Buffalo 50th Anniversary Oral Biology Graduate Program Symposium. 2013.
  • Borowitz DS, Ramsey B, Rodriguez S, Yen K, Elborn S. Nutritional Status Measures Among Persons with CF Carrying thh G551D-CFTR Mutation Who Received Ivacaftor or Placebo in Phase 3 Clinical Trials. Pediatr Pulmonol. 2012; 47(S35).
  • Coburm-Miller C, Frederick CA, Borowitz DS. Using the New Vitamin D Recommendations to Improve Vitamin D Status in Patients with CF. Pediatr Pulmonol. 2012; 47(S35).
  • Frederick CA, Valvo LE, Borowitz DS. Assessing Parent Readiness for Transition from a Pediatric to an Adult CF Program. Pediatr Pulmonol. 2012; 47(S35).
  • McKone EF, Borowitz DS, Drevenick P, Griese M, Konstan MW, Wainwright CE, Ratjen F, Sermet-Gaudelus I, Rodriguez S, Yen K, Davies JC. Long-Term Safety and Efficacy of Investigational CFTR Potentiator VX-770 in Subjects with CF. Pediatr Pulmonol. 2011; 46(S34).
  • Flume PA, Borowitz DS, Liou T, Li H, Yen K, Ordonez C, Geller DE. VX-7780 in Subjects with CF and Homozygous for the F508del CFTR Mutation. Pediatr Pulmonol. 2011; 46(S34).
  • Yen EH, Quinton HB, Borowitz DS. Better Nutritional Status in Early Childhood is Associated with Improved Clinical Outcomes and Survival in Patients with Cystic Fibrosis. Pediatr Pulmonol. 2011; 46(S34).
  • O‘Sullivan B, Baker D, Borowitz DS, Comeau A, Cleveland R, Freedman S. The Effect of Formula Fortified with Docosahexaenoic Acid (DHA) on Infants with CF. Pediatr Pulmonol. 2011; 46(S34).
  • O‘Sullivan B, Borowitz DS, Baker D, Leung K, Reed G. Natural History of Human Fecal Elastase Measurements Over the First Year of Life in Infants with CF. Pediatr Pulmonol. 2011; 46(S34).
  • Borowitz DS, Stevens C, Campion M, Brettman L. Relationship of Baseline and Treatment Coefficient of Fat Absorption to Growth in Patients with Cystic Fibrosis. Pediatr Pulmonol. 2010; 45(S33).
  • Gelfond D, Wilding G, Semler JR, O‘Hara T, Borowitz DS. Reproducibility of Proximal Small Intestinal pH Profiles in Patients with Cystic Fibrosis and Controls. Pediatr Pulmonol. 2010; 45(S33).
  • Borowitz DS, Campion M, Stevens C, Brettman L. Reproducibility of Coefficient of Fat Absorption (CFA) in Cystic Fibrosis Patients with Pancreatic Insufficiency. J Cyst Fibr. 2010; 9(Sup 1).
  • Stevens C, Brettman L, Campion M, Borowitz DS. Evaluation of Growth and Body Weight in Peri-pubertal Cystic Fibrosis (CF) Subjects Ages 7 to 20 with Exocrine Pancreatic Insufficiency (EPI) Treated with the Novel Non-Porcine Pancreatic Enzyme Replacement Therapy Liprotamase. J Cyst Fibr. 2010; 9(Sup 1).
  • Borowitz DS, Stevens C, Fratazzi C, Cohen D, Campion M. An Open-Label, International Phase III Study of the Long-term Safety of Liprotamase for Treatment of Pancreatic Insufficiency in CF. Pediatr Pulmonol. 2009; 44(S32).
  • Mann M, Poupalos J, McCarthy M, Vaughan R, Borowitz DS. Urinary Sodium to Creatinine Ratio in Healthy Infants: Preliminary Results. Pediatr Pulmonol. 2009; 44(S32).
  • Gelfond D, Wilding G, Semler JR, O‘Hara T, Borowitz DS. In vivo Intestinal pH Profiles of Patients with CF: Preliminary Data. Pediatr Pulmonol. 2009; 44(S32).
  • Asfour F, Sharp J, Ma C, Borowitz DS, Sheehan DW, Kontos M. Evaluation of the Role of a Pulmonary Exacerbation Score (PES) in Detecting Exacerbations in Outpatient Cystic Fibrosis Care. Pediatr Pulmonol. 2009; 44(S32).
  • Borowitz DS, Falzone R, Fratazzi C. A Phase 3 Study of the Efficacy and Safety of ALTU-135 (Tryizytek) for the Treatment of Pancreatic Insufficiency in CF. Pediatr Pulmonol. 2008; 43(S31).
  • Mann M, Coburn-Miller C, Borowitz DS. Predecision of Dosing Sodium Using Pre-packaged Salt Packets. Pediatr Pulmonol. 2007; 42(S30).
  • Murray FT, Borowitz DS, Konstan MW, Limauro SE, Goss C. Changes in Coefficients of Fat and Nitrogen Absorption in Subjects with Cystic Fibrosis, Pancreatic Insufficiency and Cystic Fibrosis-related Diabetes Mellitus Receiving a Novel Pancreatic Enzyme Product, ALTU-135. Pediatr Pulmonol. 2006; 41(S29).
  • McMahon A, Kontos M, Langowitz A, Russell D, Russell K, Coburn-Miller C, Sheehan DW, Sharp J, Cronin JP, Smith J, Borowitz DS. "I Had No Idea About Most of This Stuff": A Patient-Specific Annual Summary Based on the Cystic Fibrosis Foundation Registry. Pediatr Pulmonol. 2006; 41(S29).
  • Kontos M, Sheehan DW, Borowitz DS, Smith J, Sharp J, Coburn-Miller C, Rand K, Prentice S. CF Education in the First Year After Diagnosis. Pediatr Pulmonol. 2006; 41(S29).
  • Borowitz DS, Konstan MW, Goss C, Limauro SE, Murray FT. Enhanced Coefficient Fat Absorption Using a Novel Pancreatic Enzyme Preparation, ALTU-135, with Concomitant Use of a Proton Pump Inhibitor. J Cyst Fibr. 2006; 5.
  • Borowitz DS, Konstan MW, Goss C, Limauro SE, Murray FT. Correlation Between Coefficients of Fat Absorption and Nitrogen Absorption in Subjects with Cystic Fibrosis-related Pancreatic Insufficiency Treated with ALTU-135 (TheraCLEC-Total). J Cyst Fibr. 2006; 5.
  • Borowitz DS, Konstan MW, Goss C, Limauro SE, Murray FT. Treatment with ALTU-135 Results in a Positive Inverse Relationship Between Coefficient of Fat Absorption with Stool Weight in Subjects with Cystic Fibrosis-related Pancreatic Insufficiency. J Cyst Fibr. 2006; 5.
  • Konstan MW, Smith J, Borowitz DS. Improving the Quality of Care Using Parents and Patients as Consultants. Pediatr Pulmonol. 2005; 40(S28).
  • Borowitz DS, Goss C, Limauro SE, Murray FT, Casey S, Cohen M. A Dose-Ranging Study of Efficacy of TheraCLEC-Total for Treatment of Pancreatic Insufficiency. Pediatr Pulmonol. 2005; 40(S28).
  • Coburn-Miller C, Kontos M, Borowitz DS, Cronin JP. Using a Calorie Contest to Improve Nutritional Knowledge of CF Patients. Pediatr Pulmonol. 2004; 38(S27).
  • Borowitz DS, Coburn-Miller C. Discordant Results Using Different Fecal Elastase Testing Methods in Patients with CF: A Preliminary Observation. Pediatr Pulmonol. 2004; 38(S27).
  • Gibson RL, Emerson J, McNamara S, Burns JL, Rosenfeld M, Hamblett N, Acton J, Borowitz DS, Hiatt P, Konstan M, Moss R, Retsch-Bogart G, Wagener J, Waltz D, Zeitlin PL, Ramsey B. Duration of Anti-Pseudomonal Treatment Effect of Inhaled Tobramycin in Young Children with Cystic Fibrosis. Pediatr Pulmonol. 2003; 36(S25).
  • Borowitz DS, Goss CH, Stevens C, Hayes D, Newman L, O‘Rourke A, Konstan M, Wagener G, Moss R, Hendeles L, Orenstein D, Ahrens R, Oermann C, Aitken M, Mahl T. Safety and Preliminary Clinical Activity of a Novel Pancreatic Enzyme Preparation, TheraCLEC-Total, Containing Pancrease, Lipase and Amylase for the Treatment of Exocrine Pancreatic Insufficiency. Pediatr Pulmonol. 2003; 36(S25).
  • Borowitz DS, Baker SS, Baker RD, Duffy LC, Fitzpatrick LK, McClure K. Stool Elastase-1 in Patients with CF: Misclassification of Patients as Having Insufficient Pancreatic Exocrine Function. Pediatr Pulmonol. 2002; 34(S24).
  • Rand K, Arbesman M, McMahon C, Coburn-Miller C, Kontos M, Borowitz DS. Psycho-Social Stressors Predict Outcome in Patients with CF. Pediatr Pulmonol. 1999; 28(S19).
  • Vicini P, Rosenfeld M, Borowitz DS, McCoy K, McNamara S, Montgomery B, Ramsey B, Wilmott B. Population Pharmacokinetics of Inhaled Tobramycin in Cystic Fibrosis Patients Less than 6 Years of Age. Pharm Sci. 1999; Sup 1(4).
  • Coburn-Miller C, Kontos M, Borowitz DS. Does a Video Designed to Educate and Motivate Patients Impact on Caregivers?. Pediatr Pulmonol. 1994; 18(S10).
  • Millard S, Yalcin F, Wilcox A, Hudak B, Borowitz DS. Continine Levels Document Environmental Tobacco Smoke Exposure in Cystic Fibrosis Patients. Pediatr Pulmonol. 1993; 16(S9).
  • Borowitz DS, Wilcox A. Safety of Long-term Ranitidine in Patients with Cystic Fibrosis. Pediatr Pulmonol. 1993; 16(S9).
  • Kontos M, Amodeo P, Collins P, Garrett L, Leaderstorf D, Reddien M, Borowitz DS. Perceptions of the Student with CF Among Elementary School Professionals. Pediatr Pulmonol. 1993; 16(S9).
  • Borowitz DS, Harris M, Feld L, Mandal A. Amyloid Fibrils in the Urinary Sediment of Patients with Cystic Fibrosis. Pediatr Pulmonol. 1992; 14(S8).
  • Borowitz DS, Conboy K. Use of Bioelectric Impedance Analysis to Measure Body Composition in Children with CF. Pediatr Pulmonol. 1991; 11(S6).
  • Borowitz DS, Conboy K, Duffy L, Kontos M. Does Use of Parenteral Nutrition (PN) Have a Beneficial Effect on Lung Function and Weight in Patients with CF?. Pediatr Pulmonol. 1990; 9(S5).
  • Borowitz DS, Conboy K. Bioelectrical Impedance Analysis in Adults with Cystic Fibrosis. Pediatr Pulmonol. 1990; 9(S5).
  • Kontos M, Borowitz DS, Conboy K. Patient Satisfaction with Extended Use Long-Line Silastic Catheters. Pediatr Pulmonol. 1990; 9(S5).
See all (47 more)
Books and Book Chapters:
  • Carlyle B, Borowitz DS, Glick PL. "Meconium Ileus". Operative Pediatric Surgery, 2nd Edition. 2014.
  • De Lisle RC, Borowitz DS. "The CF Intestine". Cystic Fibrosis: Molecular Basis, Physiological Changes, and Therapeutic Strategies. 2012.
  • Carlyle BE, Borowitz DS, Glick PL. "Meconium Ileus". Operative Surgery, 2nd Edition. 2011.
  • Irish MS, Borowitz DS, Glick PL. "Meconium Ileus". Operative Pediatric Surgery. 2003.
  • Irish MS, Caty MG, Glick PL, Borowitz DS. "Gastrointestinal surgical aspects of cystic fibrosis". Pediatric Surgical Secrets. 2000.
  • Borowitz DS, Hudak B. "Congenital lung malformations". Pediatric Surgical Secrets. 2000.
  • Borowitz DS. "Nutrition and electrolyte therapy". Treatment of the Hospitalized Patients with CF. 1997.
  • Borowitz DS. "Childhood obesity". Current Pediatric Therapy, 15th Edition. 1994.
  • Borowitz DS. "Pediatric Nutrition". Essentials of Clinical Nutrition. 1988.

Professional Memberships:
  • North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (2005–2014)
  • American Academy of Pediatrics: Section on Pediatric Pulmonology (2000)
  • American Academy of Pediatrics: Section on Pediatric Pulmonology (1998)
  • American Academy of Pediatrics: Fellow (FAAP) (1985–present)
  • American Thoracic Society
  • Buffalo Pediatric Society
Presentations:
  • "CFTR‘s Role as a Bicarbonate Channel" Pediatric Grand Rounds, University of Wisconsin (2016)
  • "Results of the BONUS Study" Nutrition Research Seminar, University of Wisconsin (2016)
  • "Community Connections and Partnerships" Facebook Live, Cystic Fibrosis Foundation (2016)
  • "Partnerships to Support Living with CF" Midwest CF Regional Consortium (2016)
  • "How to Start and Implement a Quality Improvement Project" , University at Buffalo (2016)
  • "CFTR Modulators: Impact on Gut, Pancreas and Nutritional Status" 39th European Cystic Fibrosis Conference, European Cystic Fibrosis Society (2016)
  • "Found in Translation: Insights from Cystic Fibrosis" Stockton Kimball Lecture, University at Buffalo (2016)
  • "Beyond Chloride: Bicarbonate in the Gastrointestinal and Respiratory Tracts in Cystic Fibrosis" , Ann and Robert H. Lurie Children's Hospital (2015)
  • "CF Infant Growth and Pulmonary Status in the First Year of Life" North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (2015)
  • "Clinical Blood Hematology and Chemistry in CF Infants" North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (2015)
  • "Communication about Prognosis in Cystic Fibrosis" North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (2015)
  • "Current Challenges and Controversies in Screened Populations: CRMS/CFSPID" Consensus Conference, Cystic Fibrosis Foundation/European Cystic Fibrosis Society (2015)
  • "Pancreatic Enzyme Use in Infants with CF in the First Year of Life" North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (2015)
  • "Review of Outcomes from the Baby Observational Nutrition Study" BONUS Investigators Meeting, Cystic Fibrosis Foundation (2015)
  • "Review of Outcomes from the Baby Observational Nutrition Study" US CF Newborn Screening Quality Improvement Consortium, Cystic Fibrosis Foundation (2015)
  • "Routine Depression Screening: Patient Perceptions and Satisfaction" North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (2015)
  • "The CF-FC Adjudication Process and What We Do and Don't Know About PERT Dosing" CF Fibrosing Colonopathy Investigators Meeting, Cystic Fibrosis Foundation (2015)
  • "Using Video Conferencing for Parent and Patient Advisory Group in Era of Infection Control" North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (2015)
  • "Cystic Fibrosis: Translational Medicine and Transformational Strategy" City-Wide Grand Rounds, University at Buffalo, Department of Medicine (2015)
  • "Cystic Fibrosis: Translational Medicine and Transformational Strategy" Pediatric Grand Rounds, Women and Children‘s Hospital of Buffalo (2015)
  • "Physiological Implications of In Vivo Measurements of Gastrointestinal pH" Research Conference: Pushing the Frontiers, Cystic Fibrosis Foundation (2015)
  • "Intestinal Inflammation and Dysbiosis in Cystic Fibrosis" DIGEST National Webinar, American Gastroenterological Association (2015)
  • "Infant Nutrition in Cystic Fibrosis (Nutrición Infantil en la fibrosis quística)" 3rd Argentinean Congress of Cystic Fibrosis (2015)
  • "Pancreatic Sufficient CF (Pancreático CF Suficiente)" 3rd Argentinean Congress of Cystic Fibrosis (2015)
  • "Understanding CFTR Mutations (Entender CFTR Mutaciones)" 3rd Argentinean Congress of Cystic Fibrosis (2015)
  • "Gastrointestinal Disease in Transitioning Teenagers: Cystic Fibrosis" Annual Meeting, American College of Gastroenterology (2014)
  • "How to Digest the Facts of the Case: A Rapid Loss in Exocrine Pancreatic Function" 28th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation, Physician Grand Rounds (2014)
  • "More about Fibrosing Colonopathy and the Adjudication Process" CF Fibrosing Colonopathy Investigators Meeting (2014)
  • "PROSPECT GastroIntestinal Function Testing (GIFT) Sub-Study" PROSPECT Investigators Meeting (2014)
  • "Ways the Gut and Lungs Inform Each Other: What We have Learned from Cystic Fibrosis" Pediatric Grand Rounds, Women and Children's Hospital of Buffalo (2014)
  • "Beyond Chloride: Bicarbonate in the GI and Respiratory Tracts in CF" Annual Northwest Cystic Fibrosis Clinical Conference, Cystic Fibrosis Foundation (2014)
  • "Infant Nutrition in CF - A Small Plate Menu" Annual Northwest Cystic Fibrosis Clinical Conference, Cystic Fibrosis Foundation (2014)
  • "Nutritional Challenges in Adults Post Ivacaftor" European Cystic Fibrosis Conference, European Cystic Fibrosis Society (2014)
  • "SmartPills for Studying the Intestine in CF: Treatment Effects and Future Possibilities" European Cystic Fibrosis Conference, European Cystic Fibrosis Society (2014)
  • "What We Do and Don’t Know About PERT in Infants" European Cystic Fibrosis Conference, European Cystic Fibrosis Society (2014)
  • "Beyond Chloride: Bicarbonate in the GI and Respiratory Tracts in CF" Syracuse Regional CF Conference (2014)
  • "Cystic Fibrosis: From Bench to Bedside and Back Again" Syracuse Regional CF Conference (2014)
  • "Cystic Fibrosis: From Bench to Bedside and Back Again" Pediatric Grand Rounds, New York University Medical Center (2013)
  • "Baby Observational Nutrition Study: Implementation and Future Plans" 27th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation, BONUS Investigators Meeting (2013)
  • "CF Infant Care Guidelines: A Look at Implementation" 27th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation, Newborn Screening Interest Group (2013)
  • "Lessons Learned from the Adjunction Committee" 27th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation, CF Fibrosing Colonopathy Study Investigators Meeting (2013)
  • "Ways the Gut and Lungs Inform Each Other: What We Have Learned from Cystic Fibrosis" Stephanie Lynn Kossoff Memorial Lecture, College of Physicians and Surgeons of Columbia University and New York-Presbyterian Morgan Stanley Children's Hospital, Department of Pediatrics (2013)
  • "Effects of CFTR Modulators on the Gastrointestinal Tract" European Cystic Fibrosis Conference, European Cystic Fibrosis Society (2013)
  • "Induced Biofilm-Matrix Collapse Fluidizes Cystic Fibrosis Sputum" Oral Microbiome, Immunity and Chronic Disease Symposium, University at Buffalo (2013)
  • "Newborn Screening for CF and CRMS" Pediatric Grand Rounds, South Buffalo Mercy Hospital (2013)
  • "Pancreatic Sufficient Cystic Fibrosis" Meeting, Vertex Global Advisors (2013)
  • "Advances in Gastrointestinal Aspects of CF" 26th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation, Plenary Session (2012)
  • "GERD, DIOS and Dysmotility in Adults with CF" 26th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (2012)
  • "Practical Management of GI Issues in Adolescent and Adult Patients with CF" 26th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (2012)
  • "Update on the Baby Observational Nutrition Study (BONUS)" 26th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (2012)
  • "Measures of Nutritional Status in Two Phase 3 Trials of Invacaftor in Subjects with Cystic Fibrosis Who Have the G551D-CFTR Mutation" European Cystic Fibrosis Conference, European Cystic Fibrosis Society (2012)
  • "CF: From Bedside to Bench and Back Again" Pediatric Grand Rounds, Women and Children's Hospital of Buffalo (2012)
  • "Liquid Albuterol for Spinal Muscular Atrophy" Eastern Pediatric Teleconference, Women and Children's Hospital of Buffalo (2012)
  • "Cystic Fibrosis Research Update" Cystic Fibrosis Family Education Night, Women and Children‘s Hospital of Buffalo (2012)
  • "CFTR-Related Metabolic Syndrome: the US Perspective" Diagnostic Working Group Meeting, European Cystic Fibrosis Society (2012)
  • "An Integrated Model of Basic and Clinical Science Research: Physiology of Secretion, Cystic Fibrosis and Buffalo Entrepreneurship" Clinical Translational Lecture Series, University at Buffalo (2012)
  • "Mock Review" Pre-FDA Advisory Committee Meeting, Vertex Global Advisors (2011)
  • "Baby Observational Nutrition Study: Background and Investigator Obligations" 25th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation, BONUS Investigators (2011)
  • "Better Nutritional Status in Early Childhood is Associated with Improved Clinical Outcomes and Survival in Patients with Cystic Fibrosis" 25th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (2011)
  • "Evolution of Pancreatic Function During the First Year in Infants with Cystic Fibrosis" 25th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (2011)
  • "Fibrosing Colonopathy" 25th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation, CF-FC Investigators (2011)
  • "G551D Observational Gastrointestinal pH Sub-Study" 25th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation, Therapeutics Development Network (2011)
  • "GOAL Sub-Study: Effect of Ivacaftor on Gastrointestinal pH" 25th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation, Therapeutics Development Network (2011)
  • "Suspected Fibrosing Colonopathy" 25th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation, CF-FC Investigators (2011)
  • "What‘s New in Cystic Fibrosis Research?" Cystic Fibrosis Family Education Night, Women and Children's Hospital of Buffalo (2011)
  • "CFTR-Related Metabolic Syndrome (CRMS)" 24th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (2010)
  • "Gastrointestinal Transit Profiles in Patients with Cystic Fibrosis" Annual Meeting, North American Society of Gastroenterology, Hepatology and Nutrition (2010)
  • "Principal Investigator Responsibilities and Leadership" 24th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation, Therapeutics Development Network (2010)
  • "Reproducibility of Measurement of Intestinal Transit by Wireless Motility Capsule" Annual Meeting, American College of Gastroenterology (2010)
  • "Genomics and New Drugs for Cystic Fibrosis" Mini-Medical School Meeting, University at Buffalo (2010)
  • "New, Approved and Improved Pancreatic Enzyme Preparations" European Cystic Fibrosis Conference, European Cystic Fibrosis Society (2010)
  • "Reproducibility of Coefficient of Fat Absorption (CFA) in Cystic Fibrosis Patients with Pancreatic Insufficiency" European Cystic Fibrosis Conference, European Cystic Fibrosis Society (2010)
  • "Adenosine Deaminase Deficiency" Northern Pediatric Pulmonology Teleconference, Women and Children‘s Hospital of Buffalo (2010)
  • "Cystic Fibrosis Update 2010" Pediatric Surgical Grand Rounds, Women and Children‘s Hospital of Buffalo (2010)
  • "Pancreatic and Other Gastrointestinal Disease in Cystic Fibrosis" 1st Year Medical Student Lecture, University at Buffalo (2010)
  • "What‘s New in Cystic Fibrosis Research?" Cystic Fibrosis Family Education Night, Women and Children‘s Hospital of Buffalo (2010)
  • "Are We Close to Curing Genetic Diseases Like Cystic Fibrosis?" Grand Rounds, Wisconsin Children‘s Hospital (2010)
  • "Introduction to the New Guidelines for Care of Infants with Cystic Fibrosis" Sponsored Webinar, Cystic Fibrosis Foundation (2010)
  • "Nutrition in Cystic Fibrosis" Cystic Fibrosis Parent-Patient Education Evening, Medical College of Wisconsin, Cystic Fibrosis Center (2010)
  • "Improving Cystic Fibrosis Clinical Care and Research" Pediatric Grand Rounds, Women and Children‘s Hospital of Buffalo (2009)
  • "An Open-Label International Phase 3 Study of the Long-Term Safety of Liprotamase for Treatment of Pancreatic Insufficiency in Cystic Fibrosis" 23rd North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (2009)
  • "Cystic Fibrosis Lung Disease" 2nd Year Medical Student Lecture, University at Buffalo (2009)
  • "Introduction to the New Guidelines for Care of Infants with Cystic Fibrosis" 23rd North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (2009)
  • "Management of Pancreatic Insufficiency in Patients with Cystic Fibrosis" Hospital Meeting, Strong Memorial Hospital, University of Rochester (2009)
  • "Reproducibility of Proximal Small Intestinal pH Profiles in Patients with Cystic Fibrosis and Controls" 23rd North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (2009)
  • "Chronic Cough and Recurrent Pheumonia" Resident Noon Conference, Women and Children‘s Hospital of Buffalo (2009)
  • "Does This Patient Have Cystic Fibrosis?" Resident Noon Conference, Women and Children‘s Hospital of Buffalo (2009)
  • "Are We Close to Curing Genetic Diseases Like Cystic Fibrosis?" Pediatric Grand Rounds, Women and Children‘s Hospital of Buffalo (2008)
  • "A Phase 3 Study of the Efficacy and Safety of ALTU-135 (Trizytek) for the Treatment of Pancreatic Insufficiency in Cystic Fibrosis" 22nd North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (2008)
  • "Evidence-Based Guidelines for Care of Infants Diagnosed with Cystic Fibrosis" 22nd North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation, Newborn Screening Interest Group (2008)
  • "Cystic Fibrosis Seminar" Resident Noon Conference, Women and Children's Hospital of Buffalo (2008)
  • "CFTR and Nutrition - The Problem and Some Solutions" European Cystic Fibrosis Conference, European Cystic Fibrosis Society, Plenary Session II (2008)
  • "Smart Change Ideas to Improve Nutritional Status in Cystic Fibrosis Patients" Workshop at Learning and Leadership Collaborative VI Site Visit, Cystic Fibrosis Foundation (2008)
  • "Setting New Standards in the Management of Today‘s Cystic Fibrosis Patient: Enhancing Digestive Capacity" Annual Meeting, American Thoracic Society (2008)
  • "Nutrition as a Foundation for Good Health in Cystic Fibrosis" Cystic Fibrosis Family Education Day, Children‘s Hospital of Orange County (2008)
  • "Chronic Cough and Recurrent Pneumonia" Resident Noon Conference, Women and Children‘s Hospital of Buffalo (2008)
  • "Cystic Fibrosis Seminar" Resident Noon Conference, Women and Children‘s Hospital of Buffalo (2008)
  • "Nutrition Smart Change Ideas" Learning and Leadership Collaborative VI, Cystic Fibrosis Foundation (2008)
  • "Inhaled Aztreonam in Patients with Cystic Fibrosis" Pulmonary Biology Research Seminar, Women and Children's Hospital of Buffalo (2008)
  • "Does This Patient Have Cystic Fibrosis?" Resident Case Conference, Women and Children‘s Hospital of Buffalo (2007)
  • "Chronic Cough and Recurrent Pneumonia" Resident Noon Conference, Women and Children's Hospital of Buffalo (2007)
  • "Cystic Fibrosis" Department of Pediatrics Minority Student Lecture Series, Women and Children‘s Hospital of Buffalo (2007)
  • "How to Teach Patients to Use Inhaled Medications - Part 2" Resident Case Conference, Women and Children‘s Hospital of Buffalo (2007)
  • "Overview of Use of Pacreatic Enzyme Replacement Therapy (PERT) in Patients with Cystic Fibrosis" United States Pharmacopeial Convention, United States Pharmacopeia (2007)
  • "Cryptococcus Neoformans and Other Fungal Pneumonias" Pediatric Pulmonology Teleconference, Women and Children‘s Hospital of Buffalo (2007)
  • "Issues in Design of Pancreatic Enzyme Studies" Therapeutics Development Network Meeting, Cystic Fibrosis Foundation (2007)
  • "Successfully Negotiating the Regulatory Process in Clinical Research" General Surgery Research Retreat, Women and Children‘s Hospital of Buffalo (2007)
  • "Cystic Fibrosis Seminar" Resident Case Conference, Women and Children‘s Hospital of Buffalo (2007)
  • "‘I Had No Idea About Most of This Stuff‘: A Patient-Specific Annual Summary Based on the Cystic Fibrosis Foundation Registry" 20th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (2006)
  • "CF Education in the First Year After Diagnosis" 20th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (2006)
  • "Ethical Issues in End-of-Life Cystic Fibrosis Care" Resident Case Conference, Women and Children‘s Hospital of Buffalo (2006)
  • "Steatorrhea in Cystic Fibrosis: Not Always Due to Pancreatic Insufficiency" North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Annual Meeting, North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (2006)
  • "How to Teach Patients to Use Inhaled Medications" Resident Case Conference, Women and Children's Hospital of Buffalo (2006)
  • "Correlation Between Coefficients of Fat Absorption and Nitrogen Absorption in Subjects with Cystic Fibrosis-related Pancreatic Insufficiency Treated with ALTU-135 (TheraCLEC-Total)" European Cystic Fibrosis Conference, European Cystic Fibrosis Society (2006)
  • "Treatment with ALTU-135 Results in a Positive Inverse Relationship Between Coefficient of Fat Absorption with Stool Weight in Subjects with Cystic Fibrosis-related Pancreatic Insufficiency" European Cystic Fibrosis Conference, European Cystic Fibrosis Society (2006)
  • "How to Succeed in Clinical Research by Really Trying" Pediatric Grand Rounds, Women and Children‘s Hospital of Buffalo (2006)
  • "Correlation Between Coefficients of Fat Absorption and Nitrogen Absorption in Subjects with Cystic Fibrosis-related Pancreatic Insufficiency Treated with ALTU-135 (TheraCLEC-Total)" Digestive Diseases Week (2006)
  • "Issues in Design of Pancreatic Enzyme Studies" Division of Gastroenterology, Women and Children‘s Hospital of Buffalo (2006)
  • "Issues in Design of Pancreatic Enzyme Studies" Therapeutics Development Network Meeting, Cystic Fibrosis Foundation (2006)
  • "Gastrointestinal Complications of Cystic Fibrosis" Division of Gastroenterology, Women and Children's Hospital of Buffalo (2005)
  • "A Dose-Ranging Study of Efficacy of TheraCLEC-Total for Treatment of Pancreatic Insufficiency" 19th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (2005)
  • "Cystic Fibrosis Nutrition: Opportunities for the Clinician and Scientist" 19th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation, Plenary Session (2005)
  • "Pancreatic Enzyme Replacement Therapy in Infants and Yound Children with Cystic Fibrosis - Nuts and Bolts of Gastrointestinal Problems in Cystic Fibrosis" 19th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (2005)
  • "Use of Pancreatic Enzymes in Cystic Fibrosis" Golisano Children‘s Hospital Meeting, Strong Memorial Hospital, University of Rochester (2005)
  • "Cystic Fibrosis Can Teach You Everything You Need to Know About Gastrointestinal Physiology" 1st Year Medical Student Lecture, University at Buffalo (2005)
  • "Cystic Fibrosis Seminar" Pediatric House Staff Meeting, Women and Children‘s Hospital of Buffalo (2005)
  • "Improving the Quality of Cystic Fibrosis Care" Pediatric Grand Rounds, Women and Children‘s Hospital of Buffalo (2005)
  • "Intrabronchial Tumors" Northern Pediatric Pulmonology Teleconference, Women and Children‘s Hospital of Buffalo (2005)
  • "The Pancreas as a Regulator of Disease in Cystic Fibrosis" School of Medicine Meeting, Mt. Sinai School of Medicine (2005)
  • "Nuts and Bolts of Cystic Fibrosis" 18th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (2004)
  • "We Can Deliver Better Care: Improving Our Center Systems" 18th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (2004)
  • "Pancreatic Dysfunction in Cystic Fibrosis" Pediatric Grand Rounds, Women and Children‘s Hospital of Buffalo (2004)
  • "Safety and Preliminary Clinical Activity of a Novel Pancreatic Enzyme Preparation, TheraCLEC-Total, Containing Pancrease, Lipase and Amylase for the Treatment of Exocrine Pancreatic Insufficiency" European Cystic Fibrosis Conference, European Cystic Fibrosis Society (2004)
  • "Surfactant Protein C Deficiency" Northern Pediatric Pulmonology Teleconference, Women and Children‘s Hospital of Buffalo (2004)
  • "Recurrent Pancreatitis in Cystic Fibrosis" 17th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation, Physician‘s Grand Round (2003)
  • "Safety and Preliminary Clinical Activity of a Novel Pancreatic Enzyme Preparation, TheraCLEC-Total, Containing Pancrease, Lipase and Amylase for the Treatment of Exocrine Pancreatic Insufficiency" 17th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (2003)
  • "Cystic Fibrosis Seminar" Pediatric House Staff Meeting, Women and Children‘s Hospital of Buffalo (2003)
  • "Cystic Fibrosis Newborn Screening" New York Nurse Practitioner Association Regional Meeting, New York Nurse Practitioner Association (2003)
  • "Use of Pulmonary Function Tests in Office Practice" Pediatric Grand Rounds, Women and Children‘s Hospital of Buffalo (2003)
  • "Obstetrical Aspects of Cystic Fibrosis" OB-Gyn Grand Rounds, Women and Children‘s Hospital of Buffalo (2002)
  • "Stool Elastase-1 in Patients with CF: Misclassification of Patients as Having Insufficient Pancreatic Exocrine Function" 16th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (2002)
  • "Recommendations from the Consensus Conference on Pediatric Nutrition in Cystic Fibrosis" Consensus Conference on Osteoporosis in Cystic Fibrosis, Cystic Fibrosis Foundation (2002)
  • "Cystic Fibrosis for Primary Care Providers" Pediatric Pulmonary Update: Focus on Challenging Respiratory Diseases, Indiana University School of Medicine (2002)
  • "Up and Down: Gastroesophageal Reflux and the Lung" Pediatric Pulmonary Update: Focus on Challenging Respiratory Diseases, Indiana University School of Medicine (2002)
  • "Interventions for Patients with Inadequate Nutritional Status" 15th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (2001)
  • "State of the Art Care for Cystic Fibrosis: An International Perspective" ATS/ALA Joint Meetings, American Thoracic Society and American Lung Association, B7 Symposium (2001)
  • "Controversies and Crises in Cystic Fibrosis Care" 2001 - An Airspace Odyssey: Clinical Pediatric Pulmonary Course, American Academy of Pediatrics (2001)
  • "New Route for Old Friends - Inhaled Antibiotics" 2001 - An Airspace Odyssey: Clinical Pediatric Pulmonary Course, American Academy of Pediatrics (2001)
  • "Up and Down - Gastroesophageal reflux and the Lung" 2001 - An Airspace Odyssey: Clinical Pediatric Pulmonary Course, American Academy of Pediatrics (2001)
  • "Differential Diagnosis of Abdominal Pain in Cystic Fibrosis" 14th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (2000)
  • "Cystic Fibrosis: Common Problems in an Uncommon Disease" Grand Rounds, Women and Children‘s Hospital of Buffalo (2000)
  • "Nutritional Benefits of Chronic Intermittent Pseudomonas Aeruginosa Suppression with Tobramycin Solution for Inhalation in Adolescents" European Cystic Fibrosis Conference, European Cystic Fibrosis Society (2000)
  • "What‘s Left in the Differential Diagnosis: A Pediatric Potpourri" Grand Rounds, Sisters Hospital (2000)
  • "Cystic Fibrosis Overview with Emphasis on Adult Care Issues" Grand Rounds, Erie County Medical Center (2000)
  • "Psycho-Social Stressors Predict Outcome in Patients with CF" 13th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (1999)
  • "Does a Video Designed to Educate and Motivate Patients Impact on Caregivers?" 8th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (1994)
  • "Safety, Efficacy and Pharmacokinetics of Tobramycin (tobra) Administered by Three Different Nebulizer Delivery Systems" 8th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (1994)
  • "Growth Hormone, IGF-I and IGFI BP-3 in Patients with Cystic Fibrosis" 76th Annual Meeting, The Endocrine Society (1994)
  • "Continine Levels Document Environmental Tobacco Smoke Exposure in Cystic Fibrosis Patients" 7th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (1993)
  • "Perceptions of the Student with CF Among Elementary School Professionals" 7th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (1993)
  • "Safety of Long-term Ranitidine in Patients with Cystic Fibrosis" 7th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (1993)
  • "Aerosolized Recombinant Human DNase Reduces Pulmonary Exacerbations and Improves Pulmonary Function in Patients with Cystic Fibrosis" 36th Annual Conference on Chest Disease, Inter-Mountain Thoracic Society (1993)
  • "Amyloid Fibrils in the Urinary Sediment of Patients with Cystic Fibrosis" 6th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (1992)
  • "Hypomotile Bowel Syndrome Presenting as Meconium Ileus: A Case Report" Joint Meeting, Canadian/British Association of Pediatric Surgeons (1992)
  • "An Unusual Hepatic Mass in a Patient with Cystic Fibrosis" Annual Meeting, Society for Pediatric Radiology (1992)
  • "Use of Bioelectric Impedance Analysis to Measure Body Composition in Children with CF" 5th North American Cystic Fibrosis Conference, Cystic Fibrosis Foundation (1991)
  • "Comparison o fBioelectric Impedance Analysis in Adults with and without Cystic Fibrosis" 6th Annual National Research Program of the Chicago Lung Conference, Nutrition and the Lung (1991)
  • "Bioelectrical Impedance Analysis in Adults with Cystic Fibrosis" 4th Annual North American and 1990 International Cystic Fibrosis Conference, Cystic Fibrosis Foundation (1990)
  • "Does Use of Parenteral Nutrition (PN) Have a Beneficial Effect on Lung Function and Weight in Patients with CF?" 4th Annual North American and 1990 International Cystic Fibrosis Conference, Cystic Fibrosis Foundation (1990)
  • "Patient Satisfaction with Extended Use Long-Line Silastic Catheters" 4th Annual North American and 1990 International Cystic Fibrosis Conference, Cystic Fibrosis Foundation (1990)
  • "Cystic Fibrosis and Recurrent Pneumonia" 3rd Year Medical Student Core Lecture, University at Buffalo (1989)
See all (161 more)
Service Activities:
  • Cystic Fibrosis Foundation Research Conference: CFTR Effects in the GI and Endocrine Systems: Implications for Nutritional Status in Patients with CF; Moderator (2015)
  • Cystic Fibrosis Foundation: Strategic Investments in Care Centers Committee; Co-Chair (2015)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Ad Hoc Committee on Promotion to Clinical Ranks; Committee Member (2014–2017)
  • DIGEST (Developing Innovative Gastroenterologic Specialty Training); Organizer and Core Faculty Member (2014–2016)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Clinical Research Office Advisory Committee; Committee Member (2014–2015)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Integrating Special Populations Team; Director (2014–2015)
  • Cystic Fibrosis Foundation: Patient Engagement Advisory Committee; Committee Member (2013–2015)
  • Cystic Fibrosis Foundation: Strategic Planning Steering Committee - Sub-Group Adherence Action Team; Committee Member (2013)
  • Cystic Fibrosis Foundation: New Antioxidant Formulation for Patients with Cystic Fibrosis; Ad Hoc Reviewer (2012)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Frawley Fellowship Review Committee; Committee Member (2012)
  • Cystic Fibrosis Foundation: PACE Award (Carla Frederick, MD); Sponsor (2011–2014)
  • Cystic Fibrosis Foundation: Program for Adult Care Excellence (PACE); Ad Hoc Reviewer (2011)
  • Cystic Fibrosis Therapeutics: Therapeutics Development Network Competitive Grant Renewal; Ad Hoc Reviewer (2011)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Committee to Select Clinical Research Administrator; Committee Member (2011)
  • Cystic Fibrosis Foundation: Fibrosing Colonopathy Adjudication Committee; Chair (2011–present)
  • 24th North American Cystic Fibrosis Conference: Pediatric Clinical Fellows Sessions; Co-Chair (2010)
  • Cystic Fibrosis Foundation: Ad Hoc Committee to Review New Applications for the Therapeutics Development Network; Member (2010)
  • National Institutes of Health/National Heart, Lung and Blood Institute: Future Directions in Pathogenesis, Treatment and Prevention of Early CF; Invited Participant (2010)
  • Cystic Fibrosis Foundation/Solvay Pharmaceuticals: Design a Phase IV study for surveillance of fibrosing colonopathy in patients exposed to Creon; Consultant (2010–2011)
  • Cystic Fibrosis Foundation: Evidence-Based Review of Vitamin D in Patients with Cystic Fibrosis; Co-Chair (2010–2011)
  • European Cystic Fibrosis Conference: Gastroenterology Cases; Co-Chair (2010)
  • Vertex Pharmaceuticals: VX-770 Studies in Young Children; Advisory Board (2010–present)
  • 23rd North American Cystic Fibrosis Conference: Pediatric Clinical Fellows Sessions; Co-Chair (2009)
  • Cystic Fibrosis Foundation: Therapeutics Development Program Executive Committee; Committee Member (2009–present)
  • European Cystic Fibrosis Clinical Trials Network: Nutritional Outcomes Working Group; Invited Participant (2009–present)
  • Vertex Pharmaceuticals: Gastrointestinal Outcomes; Advisory Board (2009–present)
  • 22nd North American Cystic Fibrosis Conference: Pediatric Clinical Fellows Sessions; Co-Chair (2008)
  • Cystic Fibrosis Foundation: Therapeutics Development Network Steering Committee; Committee Member (2008–2014)
  • Working Group to Develop Consensus-Based Guidelines for Management of Infants with Uncertain Diagnosis of Cystic Fibrosis or CFTR-Related Disorder; Co-Chair (2008–2009)
  • Cystic Fibrosis Foundation: Program for Adult Care Excellence (PACE) Award; Reviewer (2008)
  • National Institutes of Health/Cystic Fibrosis Foundation: Longitudinal Study of Cystic Fibrosis Liver Disease Executive and Steering Committees; Committee Member (2008–present)
  • 21st North American Cystic Fibrosis Conference: Pediatric Clinical Fellows Sessions; Co-Chair (2007)
  • Workshop to Develop Evidence-Based Guidelines for Management of Infants Diagnosed with Cystic Fibrosis by Newborn Screening; Co-Chair (2007–2009)
  • 20th North American Cystic Fibrosis Conference: Pediatric Clinical Fellows Sessions; Co-Chair (2006)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Faculty Promotion Committee (Pediatrics); Committee Member (2006–2015)
  • Cystic Fibrosis Foundation: Nutrition Guidelines Committee; Chair (2006–2012)
  • Cystic Fibrosis Foundation/NIH - Rare Diseases Network: Planning Committee to Study Cystic Fibrosis Hepatobiliary Disease; Chair (2006–2008)
  • Cystic Fibrosis Foundation: Clinical Research Facilitation Awards Review Committee; Committee Member (2006)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Search Committee for Chief of General Pediatrics; Chair (2006)
  • 19th North American Cystic Fibrosis Conference: Pediatric Clinical Fellows Sessions; Co-Chair (2005)
  • Cystic Fibrosis Foundation: Workshop on Developing Evidence-Based Guidelines; Johns Hopkins University/Cochrane Collaboration; Participant (2005)
  • Cystic Fibrosis Foundation: Quality Improvement Leadership Development; Participant (2005)
  • Cystic Fibrosis Foundation: Data Safety Monitoring Board; Member (2005–2015)
  • Cystic Fibrosis Foundation: Food and Drug Administration; Consultant (2005–2015)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Ad Hoc Committee on Promotions and Tenure; Committee Member (2005–2007)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Ad Hoc Committee on Promotions and Tenure (Pediatrics); Committee Member (2005–2007)
  • Cystic Fibrosis Foundation: Gastrointestinal Outcomes and Confounders in Cystic Fibrosis; Co-Chair (2005)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Faculty Practice Management Plan Governing Board; Alternate Delegate (2005)
  • 18th North American Cystic Fibrosis Conference: Pediatric Clinical Fellows Sessions; Co-Chair (2004)
  • Cystic Fibrosis Foundation: Quality Improvement Strategic Planning Advisory Committee; Committee Member (2004–2008)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Committee on Promotions to Clinical Ranks; Committee Member (2004–2007)
  • Cystic Fibrosis Foundation: Clinical Practice Guidelines Subcommittee on Growth and Nutrition; Committee Member (2004–2006)
  • Cystic Fibrosis Foundation: Workshop on Implementation of Newborn Screening for Cystic Fibrosis; Invited Participant (2004)
  • 17th North American Cystic Fibrosis Conference: Fellows Case Presentations; Moderator (2003)
  • 17th North American Cystic Fibrosis Conference: Pediatric Clinical Fellows Sessions; Co-Chair (2003)
  • Cystic Fibrosis Foundation/Intermountain Health Corporation: Mini-Advanced Training Program for Health Care Delivery; Participant (2003–2004)
  • Association of Clinical Research Professionals: Good Clinical Practices for Research Investigators; Participant (2003)
  • Cystic Fibrosis Foundation: Workshop on Antioxidants in Cystic Fibrosis; Chair (2003)
  • Centers for Disease Control and Prevention: Conference on Newborn Screening in Cystic Fibrosis; Invited Participant (2003)
  • Cystic Fibrosis Foundation: Consensus Conference on Bone Health in Patients with Cystic Fibrosis; Member (2002)
  • Women and Children‘s Hospital of Buffalo: Committee to Build a New Outpatient Facility; Committee Member (2001–2003)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Faculty Practice Management Plan Governing Board; School Representative (2001)
  • American Thoracic Society: International Conference Committee Advisory Group; Member (2000)
  • Cystic Fibrosis Foundation: Nutrition for Pediatric Patients with Cystic Fibrosis; Co-Chair (2000)
  • American Journal Respiratory and Critical Care Medicine; Reviewer (2000–present)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Ad Hoc Committee on Promotions to Qualified (Clinical) Ranks; Committee Member (1998–2001)
  • Harvard School of Public Health: Leadership Development for Physicians in Academic Centers; Participant (1997)
  • Cystic Fibrosis Foundation: North American Cystic Fibrosis Conference Program Planning Committee; Committee Member (1997–2001)
  • UBMD Pediatrics: Finance Committee; Committee Member (1997–2000)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Budget Priorities Committee; Committee Member (1997–1998)
  • Centers for Disease Control and Prevention: Workshop on Cystic Fibrosis Newborn Screening; Invited Participant (1997)
  • Cystic Fibrosis Foundation: Ad Hoc Task Force on Transition of Adult Cystic Fibrosis Care; Participant (1997–present)
  • American Thoracic Society: Pediatric Assembly Long-Range Planning Committee; Committee Member (1996–2001)
  • Cystic Fibrosis Foundation: Center Committee; Chair (1996–2001)
  • Cystic Fibrosis Foundation: Medical Advisory Committee; Committee Member (1996–2001)
  • Women Health Professionals: Endowment Fund; President (1996–2000)
  • Women and Children‘s Hospital of Buffalo: Multispecialty Procedure Area; Founder and Director (1996–1998)
  • Cystic Fibrosis Foundation: North American Cystic Fibrosis Meetings; Invited to develop a short course in Management of Growth and Nutrition in CF (1996–1997)
  • Cystic Fibrosis Foundation: North American Cystic Fibrosis Conference Program Planning Committee; Co-Chair (1996)
  • Journal of Pediatrics; Reviewer (1996–present)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Benefits Committee; Committee Member (1995–1997)
  • Women and Children‘s Hospital of Buffalo: Medical/Dental Staff Executive Committee; Committee Member (1995–1997)
  • Cystic Fibrosis Foundation: Consensus Conference on Cystic Fibrosis and Colonic Strictures; Chair (1995–1996)
  • Cystic Fibrosis Foundation: Practice Guidelines Committee; Committee Member (1995–1996)
  • Alpha I. Biomedicals, Inc.: Thymosin B4 Medical Advisory Board; Member (1995)
  • Journal of Pediatric Pulmonology; Reviewer (1995–present)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Ad Hoc Committee on Commercial Support of Continuing Medical Education; Committee Member (1993–1998)
  • Women Health Professionals: Endowment Fund Program Committee; Chair (1993–1996)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Ad Hoc Committee on Family Issues for Faculty (Pediatrics); Chair (1993–1995)
  • Cystic Fibrosis Foundation: Consensus Conference on Use of Nebulized rhDNase; Member (1993)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Appeals Committee; Committee Member (1993)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Pulmonary Medicine for Community Pediatricians Course (Category I CME); Coordinator (1993)
  • Women Health Professionals: Endowment Fund; Co-Founder (1993)
  • Women and Children‘s Hospital of Buffalo: Pastor Lecture Committee; Committee Member (1992–1998)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Pediatric Grand Rounds; Coordinator (1992–1997)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Pediatric Grand Rounds Committee; Chair (1992–1997)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Pediatric Curriculum Committee; Committee Member (1992–1995)
  • Genentech: rhDNase I Medical Advisory Board; Member (1992–1993)
  • Cystic Fibrosis Foundation: Advisory Group; Randomized Clinical Trial of Ursodeoxycholic Acid in the Treatment of Cystic Fibrosis-Associated Liver Disease; Member (1991–1994)
  • Cystic Fibrosis Foundation: Consensus Conference on Gastrointestinal Problems in Cystic Fibrosis; Section Leader - Distal Ileal Obstruction Syndrome (1991)
  • Cystic Fibrosis Foundation: Western New York Chapter; Board Member (1990–2015)
  • Cystic Fibrosis Foundation: Center Committee; Committee Member (1990–1996)
  • Erie County Nutrition Committee; Committee Member (1990–1992)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Standing Committee of Appointments, Promotions and Tenure; Committee Member (1990–1992)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Faculty Council; Member (1989–1991)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Medical Students; Advisor (1989–present)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Pediatric Resident Recruitment Committee; Committee Member (1989–present)
  • Journal of Pediatric Gastroenterology and Nutrition; Reviewer (1988–present)
  • Cystic Fibrosis Foundation: Rising Stars Luncheon (2011, 2012); Participant

School News:
In the Media:

Clinical Specialties:
Clinical Offices:
Insurance Accepted:


Contact Information

Women and Children‘s Hospital of Buffalo
Division of Pulmonology
140 Hodge Avenue
Buffalo, NY 14222
Phone: (716) 878-7524
Fax: (716) 888-3945
Email: borowitz@buffalo.edu


Log in to Update Your Profile